Skip to main content

SINC-Based Contraceptive Care, Postpartum

CBE ID
3682e
1.4 Project
Perinatal and Women's Health
Endorsed
Endorsement Status
Endorsed
1.1 New or Maintenance
Maintenance
E&M Cycle
Spring 2022
Is Under Review
No
Next Planned Maintenance Review
Perinatal and Women's Health Spring 2026
1.3 Measure Description

Percentage of women 1) who received or had documented use of most or moderately effective contraception during the postpartum period (primary measure) and 2) received a long-acting reversible contraceptive method during the postpartum period (sub-measure). To focus the measure on the population of women interested in contraceptive services, the denominator excludes those individuals who did not receive or have documented use of a method if they indicated they did not want these services. 

 

    • 1.14 Numerator

      Primary measure: All eligible patients who received a most or moderately effective method in the postpartum period

      Sub-measure: Of eligible patients, those who received a long-acting reversible contraceptive method (intrauterine device or implant) during the postpartum period.

    • 1.15 Denominator

      All women between ages 15-44 with a prenatal care visit between 1/1/XX-1 and 12/31/XX with a live birth date, if documented, or a documented EDD between 10/1/XX-1 and 9/30/XX

    • Exclusions
      1. Those who indicated they did not want contraceptive services and did not receive or were documented to be using a most or moderately effective method in the postpartum period
      2. Those who experienced a non-live birth between 10/1/XX-1 and 9/30/XX (e.g. still birth, miscarriage, ectopic pregnancy, or induced abortion)
    • Most Recent Endorsement Activity
      Endorsed Perinatal and Women's Health Spring 2022
      Initial Endorsement
      Last Updated